Developing Antibody Drug (Alloy Therapeutics / Tahoe) Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Developing Antibody Drug (Alloy Therapeutics / Tahoe) General Information

Description

Developer of an antibody drug intended for patients with cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • South San Francisco, CA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • South San Francisco, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Developing Antibody Drug (Alloy Therapeutics / Tahoe) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Developing Antibody Drug (Alloy Therapeutics / Tahoe)‘s full profile, request access.

Request a free trial

Developing Antibody Drug (Alloy Therapeutics / Tahoe) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Developing Antibody Drug (Alloy Therapeutics / Tahoe)‘s full profile, request access.

Request a free trial

Developing Antibody Drug (Alloy Therapeutics / Tahoe) FAQs

  • When was Developing Antibody Drug (Alloy Therapeutics / Tahoe) founded?

    Developing Antibody Drug (Alloy Therapeutics / Tahoe) was founded in 2026.

  • Where is Developing Antibody Drug (Alloy Therapeutics / Tahoe) headquartered?

    Developing Antibody Drug (Alloy Therapeutics / Tahoe) is headquartered in South San Francisco, CA.

  • What industry is Developing Antibody Drug (Alloy Therapeutics / Tahoe) in?

    Developing Antibody Drug (Alloy Therapeutics / Tahoe)’s primary industry is Drug Discovery.

  • Is Developing Antibody Drug (Alloy Therapeutics / Tahoe) a private or public company?

    Developing Antibody Drug (Alloy Therapeutics / Tahoe) is a Private company.

  • What is Developing Antibody Drug (Alloy Therapeutics / Tahoe)’s current revenue?

    The current revenue for Developing Antibody Drug (Alloy Therapeutics / Tahoe) is .

  • Who are Developing Antibody Drug (Alloy Therapeutics / Tahoe)’s investors?

    Alloy Therapeutics and Tahoe Therapeutics have invested in Developing Antibody Drug (Alloy Therapeutics / Tahoe).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process